- Filed
- Nov 15, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 12, 2021 | 8.42M sh |
| Short Term Debt | Q3 2021 · Sep 30, 2021 | $209.43M |
| Short Term Debt | Q3 2021 · Dec 31, 2020 | $202.75M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $9.05M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $2.78M |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $236.97M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $219.32M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $245.46M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $230.73M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $24.86M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $24.05M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $134.33M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $157.76M |
| Shares Diluted restated | Q3 2021 · Sep 30, 2020 | 8.36K sh |
| Shares Diluted restated | Q3 2021 · Sep 30, 2020 | 8.37K sh |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | $10.73M |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | −$4.24M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | $62.61M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | $103.82M |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$8.80 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$13.80 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$8.80 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$13.80 |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $2.1M |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $6.51M |
| Net Income | Q3 2021 · Sep 30, 2020 | −$73.62M |
| Net Income | Q3 2021 · Sep 30, 2020 | −$115.43M |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$56.66M |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$147.92M |
| Revenue | Q3 2021 · Sep 30, 2020 | $12.6M |
| Revenue | Q3 2021 · Sep 30, 2020 | $30.31M |